Find clinical trials for Bristol Myers Squibb. Search for Bristol Myers Squibb clinical trials in different cities and states across the United States.
Filter
Filter results
Results: 87
Active & Responsive
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
for
Bipolar Disorder Type I With Mania
Location: New Haven CT, Staten Island NY, Marlton NJ,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18 - 65
Code: NCT06929273
Phase3, Recruiting
Active & Responsive
A Study to Evaluate the Effect of KarXT on Urological Safety
for
Schizophrenia
Location: Marlton NJ, Philadelphia PA, West Palm Beach FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18 - 65
Code: NCT07221877
Recruiting
Active & Responsive
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
for
Alzheimer Disease
Location: North Dartmouth MA, Boston MA, Belmont MA,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All
Age: 55 - 70+
Code: NCT06585787
Phase3, Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
for
Mania, Bipolar Disorder
Location: Staten Island NY, Hallandale FL, West Palm Beach FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18 - 65
Code: NCT07140913
Phase3, Recruiting
Active & Responsive
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)
Location: Worcester MA, New York NY, Summit NJ, Chapel Hill NC,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT05869955
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis
for
Systemic Sclerosis
Location: Atlanta GA, Aurora CO
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 16+
Code: NCT07335562
Phase3, Recruiting
New
A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment
for
Healthy Volunteers, Hepatic Impairment
Location: Miami Lakes FL, San Antonio TX, Chandler AZ
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18 - 70+
Code: NCT07248839
Phase1, Recruiting
New
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
for
Refractory Autoimmune Diseases
Location: Boston MA, Durham NC
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT07115745
Phase1, Recruiting
New
A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
for
Ulcerative Colitis
Location: Wilmington NC
Sponsor: Bristol-Myers Squibb
Sex: Female
Age: 0+
Code: NCT05953402
Recruiting
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors